# EDGAR Filing Document

**Accession Number:** 0001559109
**File Stem:** 0001752724-23-073263
**Filing Date:** 2023-3
**Character Count:** 52638
**Document Hash:** 180c4c520bd2d41cc553db11986d6e6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-073263.hdr.sgml**: 20230330

**ACCESSION NUMBER**: 0001752724-23-073263

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230330

**DATE AS OF CHANGE**: 20230330

**PERIOD START**: 20231031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ETFis Series Trust I
- **CENTRAL INDEX KEY:** 0001559109
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22819
- **FILM NUMBER:** 23778031

**BUSINESS ADDRESS:**
- **STREET 1:** 1540 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 347-903-7347

**MAIL ADDRESS:**
- **STREET 1:** 1540 BROADWAY
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ETF Actively Managed Trust
- **DATE OF NAME CHANGE:** 20120926

## Series and Classes Contracts Data

### Virtus LifeSci Biotech Clinical Trials ETF (Series ID: S000047353)

| Class ID   | Class Name                                 | Ticker Symbol   |
|:---|:---|:---|
| C000148681 | Virtus LifeSci Biotech Clinical Trials ETF | BBC             |

## Nport-Ex

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF

January 31, 2023 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description** | **Shares** | **Value** |
| **COMMON STOCKS - 97.7%** |  |  |
| **Health Care - 97.0%** |  |  |
| 4D Molecular Therapeutics, Inc.\* | 4899 | $103124 |
| AbCellera Biologics, Inc. (Canada)\* | 11821 | 124475 |
| Adicet Bio, Inc.\* | 11254 | 102974 |
| Affimed NV (Germany)\* | 101477 | 130905 |
| Agenus, Inc.\* | 44514 | 116182 |
| Akero Therapeutics, Inc.\* | 2704 | 133848 |
| Alector, Inc.\* | 12765 | 112587 |
| Allakos, Inc.\* | 17081 | 126912 |
| Allogene Therapeutics, Inc.\*<sup>(1)</sup> | 15471 | 119436 |
| Allovir, Inc.\* | 17872 | 103300 |
| Altimmune, Inc.\* | 11107 | 151500 |
| ALX Oncology Holdings, Inc.\* | 10672 | 99250 |
| AnaptysBio, Inc.\*<sup>(1)</sup> | 4082 | 101601 |
| Arbutus Biopharma Corp.\* | 44022 | 132506 |
| Arcellx, Inc.\* | 3629 | 121245 |
| Arcturus Therapeutics Holdings, Inc.\* | 6353 | 134239 |
| Arcus Biosciences, Inc.\* | 3562 | 77046 |
| Arcutis Biotherapeutics, Inc.\* | 7201 | 119321 |
| Arrowhead Pharmaceuticals, Inc.\* | 3646 | 127574 |
| Arvinas, Inc.\* | 3181 | 104241 |
| ATAI Life Sciences NV (Germany)\* | 38626 | 68754 |
| Atara Biotherapeutics, Inc.\* | 30860 | 156460 |
| Atea Pharmaceuticals, Inc.\* | 27152 | 125714 |
| Avidity Biosciences, Inc.\* | 7023 | 166445 |
| Bicycle Therapeutics PLC (United Kingdom)\*<sup>(1)(2)</sup> | 3729 | 102995 |
| Biohaven Ltd.\* | 7622 | 145504 |
| Bioxcel Therapeutics, Inc.\* | 6269 | 178792 |
| C4 Therapeutics, Inc.\* | 14620 | 113890 |
| Cara Therapeutics, Inc.\* | 10244 | 119650 |
| Caribou Biosciences, Inc.\* | 14673 | 105792 |
| Cassava Sciences, Inc.\*<sup>(1)</sup> | 2715 | 76020 |
| Celldex Therapeutics, Inc.\* | 2974 | 131034 |
| Cerevel Therapeutics Holdings, Inc.\*<sup>(1)</sup> | 4455 | 152138 |
| Chinook Therapeutics, Inc.\* | 4796 | 121195 |
| CinCor Pharma, Inc.\* | 9879 | 285799 |
| Codexis, Inc.\* | 21460 | 131979 |
| Cogent Biosciences, Inc.\* | 9896 | 149034 |
| Compass Pathways PLC (United Kingdom)\*<sup>(1)(2)</sup> | 11880 | 123314 |
| Crinetics Pharmaceuticals, Inc.\* | 7350 | 144134 |
| CRISPR Therapeutics AG (Switzerland)\* | 2385 | 121683 |
| Cullinan Oncology, Inc.\* | 10045 | 116924 |
| CureVac NV (Germany)\* | 16699 | 179347 |
| Cytokinetics, Inc.\* | 2893 | 122895 |
| Day One Biopharmaceuticals, Inc.\* | 5542 | 120649 |
| Denali Therapeutics, Inc.\* | 3892 | 117811 |
| Design Therapeutics, Inc.\* | 13484 | 105849 |
| DICE Therapeutics, Inc.\* | 3529 | 112116 |
| Dynavax Technologies Corp.\* | 10367 | 117976 |
| Dyne Therapeutics, Inc.\* | 8676 | 126670 |
| Edgewise Therapeutics, Inc.\* | 14802 | 151424 |
| Editas Medicine, Inc.\*<sup>(1)</sup> | 11558 | 114309 |
| EQRx, Inc.\* | 49075 | 120234 |
| Erasca, Inc.\* | 24740 | 98960 |
| Fate Therapeutics, Inc.\* | 7791 | 46434 |
| FibroGen, Inc.\* | 7947 | 187549 |
| Geron Corp.\* | 50954 | 168148 |
| Ideaya Biosciences, Inc.\* | 7061 | 120249 |
| IGM Biosciences, Inc.\* | 6050 | 137517 |
| I-Mab (China)\*<sup>(2)</sup> | 31182 | 187716 |
| Immatics NV (Germany)\* | 12396 | 100532 |
| ImmunityBio, Inc.\*<sup>(1)</sup> | 17766 | 67511 |
| Immunovant, Inc.\* | 7930 | 140916 |
| Inhibrx, Inc.\* | 4071 | 101775 |
| Inovio Pharmaceuticals, Inc.\* | 64033 | 106295 |
| Intellia Therapeutics, Inc.\* | 3086 | 130970 |
| Iovance Biotherapeutics, Inc.\* | 17766 | 141417 |
| iTeos Therapeutics, Inc.\* | 5660 | 118294 |
| IVERIC bio, Inc.\* | 5375 | 124163 |
| Karuna Therapeutics, Inc.\* | 585 | 116643 |
| Keros Therapeutics, Inc.\* | 2384 | 139631 |
| Kezar Life Sciences, Inc.\* | 16607 | 119072 |
| Kodiak Sciences, Inc.\* | 16426 | 132722 |
| Krystal Biotech, Inc.\*<sup>(1)</sup> | 1542 | 128171 |
| Kura Oncology, Inc.\* | 9091 | 125638 |
| Kymera Therapeutics, Inc.\*<sup>(1)</sup> | 4043 | 151127 |
| Lyell Immunopharma, Inc.\*<sup>(1)</sup> | 33635 | 109986 |
| Madrigal Pharmaceuticals, Inc.\* | 2051 | 591201 |
| Mersana Therapeutics, Inc.\* | 16772 | 110360 |
| Merus NV (Netherlands)\* | 8640 | 134784 |
| Mirati Therapeutics, Inc.\*<sup>(1)</sup> | 2739 | 146290 |
| Morphic Holding, Inc.\* | 4359 | 142670 |
| NGM Biopharmaceuticals, Inc.\* | 22381 | 117276 |
| Nkarta, Inc.\* | 16359 | 87193 |
| Novavax, Inc.\*<sup>(1)</sup> | 6949 | 75814 |
| Nurix Therapeutics, Inc.\* | 9688 | 119066 |
| Nuvalent, Inc. Class A\* | 3702 | 111986 |
| Nuvation Bio, Inc.\* | 66522 | 163644 |
| Pliant Therapeutics, Inc.\* | 6243 | 218755 |
| PMV Pharmaceuticals, Inc.\*<sup>(1)</sup> | 12331 | 101114 |
| Point Biopharma Global, Inc.\*<sup>(1)</sup> | 17635 | 141080 |
| Precigen, Inc.\* | 70024 | 113439 |
| Prometheus Biosciences, Inc.\* | 1101 | 125140 |
| Protagonist Therapeutics, Inc.\* | 12169 | 161726 |
| Prothena Corp. PLC (Ireland)\* | 2066 | 116832 |
| RAPT Therapeutics, Inc.\* | 6519 | 189377 |
| Reata Pharmaceuticals, Inc. Class A\*<sup>(1)</sup> | 3399 | 147279 |
| Recursion Pharmaceuticals, Inc. Class A\*<sup>(1)</sup> | 13116 | 109256 |
| REGENXBIO, Inc.\* | 5037 | 116909 |
| Relay Therapeutics, Inc.\*<sup>(1)</sup> | 6842 | 146829 |
| Repare Therapeutics, Inc. (Canada)\* | 8058 | 99597 |
| Replimune Group, Inc.\* | 4291 | 119504 |
| REVOLUTION Medicines, Inc.\* | 4933 | 131908 |
| Rocket Pharmaceuticals, Inc.\* | 5260 | 114300 |
| Sangamo Therapeutics, Inc.\* | 34708 | 121131 |
| Scilex Holding Co. (Singapore)\* | 17635 | 125229 |
| Seres Therapeutics, Inc.\* | 19344 | 105812 |
| Sorrento Therapeutics, Inc.\* | 106912 | 102475 |
| SpringWorks Therapeutics, Inc.\* | 5110 | 160454 |
| Stoke Therapeutics, Inc.\* | 14289 | 142318 |
| Summit Therapeutics, Inc.\* | 36619 | 129997 |
| Syndax Pharmaceuticals, Inc.\* | 4873 | 139855 |
| TG Therapeutics, Inc.\* | 13086 | 199300 |
| uniQure NV (Netherlands)\* | 5091 | 108184 |
| Vaxcyte, Inc.\* | 2620 | 118817 |

---

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF (continued)

January 31, 2023 (unaudited)

---

| | | |
|:---|:---|:---|
| **Security Description** | **Shares** | **Value** |
| **COMMON STOCKS (continued)** |  |  |
| **Health Care (continued)** |  |  |
| Ventyx Biosciences, Inc.\* | 3527 | $148134 |
| Verve Therapeutics, Inc.\* | 5295 | 120461 |
| Vir Biotechnology, Inc.\* | 4624 | 136639 |
| Viridian Therapeutics, Inc.\* | 4289 | 156634 |
| Xencor, Inc.\* | 4199 | 138231 |
| Xenon Pharmaceuticals, Inc. (Canada)\* | 3092 | 120866 |
| Zentalis Pharmaceuticals, Inc.\* | 5992 | 141411 |
| Zymeworks, Inc.\* | 18652 | 176261 |
| Total Health Care |  | 16115770 |
| **Materials - 0.7%** |  |  |
| Amyris, Inc.\*<sup>(1)</sup> | 68035 | 108176 |
| **Total Common Stocks** |  |  |
| (Cost $20,824,972) |  | **16223946** |
| **SECURITIES LENDING COLLATERAL - 3.5%** |  |  |
| **Money Market Fund - 3.5%** |  |  |
| Dreyfus Government Cash Management Fund, Institutional Shares, 4.23%<sup>(3)(4)</sup> |  |  |
| (Cost $587,712) | 587712 | **587712** |
| **TOTAL INVESTMENTS - 101.2%** |  |  |
| (Cost $21,412,684) |  | **16811658** |
| Liabilities in Excess of Other Assets - (1.2)% |  | (202737) |
| **Net Assets - 100.0%** |  | $**16608921** |

---

\* Non-income producing security.

(1) All or a portion of the security was on loan. The aggregate market value of securities on loan was $1,779,241; total market value of collateral held by the Fund was $1,815,548. Market value of the collateral held includes non-cash U.S. Treasury securities having a value of $1,227,836.

(2) American Depositary Receipts.

(3) Represents securities purchased with cash collateral received for securities on loan.

(4) The rate shown reflects the seven-day yield as of January 31, 2023.

Schedule of Investments - Virtus LifeSci Biotech Clinical Trials ETF (continued)

January 31, 2023 (unaudited)

---

| |
|:---|
| **Fair Value Measurements** |
| The Fund utilizes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 includes unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access. Level 2 includes observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data. Level 3 includes unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available; representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and would be based on the best information available. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. |
| The following table summarizes valuation of the Fund's investments under the fair value hierarchy levels as of January 31, 2023. |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Asset Valuation Inputs** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | $16098717 | $125229 | $— | $16223946 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money Market Fund | 587712 |  |  | 587712 |
| Total | $16686429 | $125229 | $— | $16811658 |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ETFis Series Trust I

- **b. Investment Company Act file number:** 811-22819

- **c. CIK number of Registrant:** 0001559109

- **d. LEI of Registrant:** 5493002CWTVLBPSYFT98

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 31 West 52nd Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10019

  - **Telephone number:** 347-903-7347

**Item A.2. Information about the Series.**

- **a. Name of Series:** Virtus LifeSci Biotech Clinical Trials ETF

- **b. EDGAR series identifier (if any):** S000047353

- **c. LEI of Series:** 549300YTBZ16PIXEKJ82

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-10-31

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $17229543.94

**Total Liabilities:** $620623.41

**Net Assets:** $16608920.53

**Cash Not Reported:** $411806.26

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000148681 | -1.86%               | -1.73%               | 10.90%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $-327220.50                                |
| Month 2  | $-2436408.40             | $2138319.93                                |
| Month 3  | $627070.49               | $965464.90                                 |

### Schedule of Portfolio Investments

| Name                               | Title                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| DREYFUS GOVERNMENT CASH MANAGEMENT | DREYFUS GOVERNMENT CASH MANAGEMENT | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    587712 | NS      | $587712.30    | 3.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Design Therapeutics Inc            | Design Therapeutics Inc            | CUSIP: 25056L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13484 | NS      | $105849.40    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| NGM Biopharmaceuticals Inc         | NGM Biopharmaceuticals Inc         | CUSIP: 62921N105<br>LEI: 5493008V5DSDZIGQOP17 | Long             | EC               | CORP              | US        |     22381 | NS      | $117276.44    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| CureVac NV                         | CureVac NV                         | CUSIP: 000000000<br>LEI: 724500BUT8GAG9LMYN56 | Long             | EC               | CORP              | DE        |     16699 | NS      | $179347.26    | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Mersana Therapeutics Inc           | Mersana Therapeutics Inc           | CUSIP: 59045L106<br>LEI: 529900VWD5VDZ7PVOS22 | Long             | EC               | CORP              | US        |     16772 | NS      | $110359.76    | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Atara Biotherapeutics Inc          | Atara Biotherapeutics Inc          | CUSIP: 046513107<br>LEI: 549300WBXUXZRE03MS38 | Long             | EC               | CORP              | US        |     30860 | NS      | $156460.20    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp             | Arbutus Biopharma Corp             | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | US        |     44022 | NS      | $132506.22    | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc          | Viridian Therapeutics Inc          | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |      4289 | NS      | $156634.28    | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc        | Arcutis Biotherapeutics Inc        | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7201 | NS      | $119320.57    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                           | Merus NV                           | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |      8640 | NS      | $134784.00    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunityBio Inc                    | ImmunityBio Inc                    | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |     17766 | NS      | $67510.80     | 0.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Prometheus Biosciences Inc         | Prometheus Biosciences Inc         | CUSIP: 74349U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1101 | NS      | $125139.66    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Fate Therapeutics Inc              | Fate Therapeutics Inc              | CUSIP: 31189P102<br>LEI: 549300L14Q4UHOODLA90 | Long             | EC               | CORP              | US        |      7791 | NS      | $46434.36     | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc              | Arcus Biosciences Inc              | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3562 | NS      | $77046.06     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| EQRx Inc                           | EQRx Inc                           | CUSIP: 26886C107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     49075 | NS      | $120233.75    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc      | Arrowhead Pharmaceuticals Inc      | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |      3646 | NS      | $127573.54    | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                | Krystal Biotech Inc                | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      1542 | NS      | $128171.04    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Novavax Inc                        | Novavax Inc                        | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |      6949 | NS      | $75813.59     | 0.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Sorrento Therapeutics Inc          | Sorrento Therapeutics Inc          | CUSIP: 83587F202<br>LEI: 549300RH23PRR3M13410 | Long             | EC               | CORP              | US        |    106912 | NS      | $102475.15    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Point Biopharma Global Inc         | Point Biopharma Global Inc         | CUSIP: 730541109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17635 | NS      | $141080.00    | 0.85%             |  |  |  | No            |                  1 | On Loan: —       |
| MADRIGAL PHARMACEUTICALS INC       | MADRIGAL PHARMACEUTICALS INC       | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      2051 | NS      | $591200.75    | 3.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc             | Relay Therapeutics Inc             | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6842 | NS      | $146829.32    | 0.88%             |  |  |  | No            |                  1 | On Loan: —       |
| iTeos Therapeutics Inc             | iTeos Therapeutics Inc             | CUSIP: 46565G104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5660 | NS      | $118294.00    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                      | REGENXBIO Inc                      | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |      5037 | NS      | $116908.77    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc            | Avidity Biosciences Inc            | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7023 | NS      | $166445.10    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Adicet Bio Inc                     | Adicet Bio Inc                     | CUSIP: 007002108<br>LEI: 549300VRD2QO80WBOP18 | Long             | EC               | CORP              | US        |     11254 | NS      | $102974.10    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Nkarta Inc                         | Nkarta Inc                         | CUSIP: 65487U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16359 | NS      | $87193.47     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| PMV Pharmaceuticals Inc            | PMV Pharmaceuticals Inc            | CUSIP: 69353Y103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12331 | NS      | $101114.20    | 0.61%             |  |  |  | No            |                  1 | On Loan: —       |
| Arvinas Inc                        | Arvinas Inc                        | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3181 | NS      | $104241.37    | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc        | Iovance Biotherapeutics Inc        | CUSIP: 462260100<br>LEI: 549300220Z2GHH33XL82 | Long             | EC               | CORP              | US        |     17766 | NS      | $141417.36    | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Cara Therapeutics Inc              | Cara Therapeutics Inc              | CUSIP: 140755109<br>LEI: 549300COVOY41P0GZ881 | Long             | EC               | CORP              | US        |     10244 | NS      | $119649.92    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Agenus Inc                         | Agenus Inc                         | CUSIP: 00847G705<br>LEI: 529900NDQQGU5H4UJK81 | Long             | EC               | CORP              | US        |     44514 | NS      | $116181.54    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Bioxcel Therapeutics Inc           | Bioxcel Therapeutics Inc           | CUSIP: 09075P105<br>LEI: 549300Y25FYZ0E8LW260 | Long             | EC               | CORP              | US        |      6269 | NS      | $178791.88    | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc            | Denali Therapeutics Inc            | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |      3892 | NS      | $117810.84    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Keros Therapeutics Inc             | Keros Therapeutics Inc             | CUSIP: 492327101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2384 | NS      | $139630.88    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings     | Arcturus Therapeutics Holdings Inc | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6353 | NS      | $134238.89    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc             | Ideaya Biosciences Inc             | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |      7061 | NS      | $120248.83    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc          | Xenon Pharmaceuticals Inc          | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |      3092 | NS      | $120866.28    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| REVOLUTION Medicines Inc           | REVOLUTION Medicines Inc           | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      4933 | NS      | $131908.42    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| AbCellera Biologics Inc            | AbCellera Biologics Inc            | CUSIP: 00288U106<br>LEI: 9845000861BC95FF9F73 | Long             | EC               | CORP              | CA        |     11821 | NS      | $124475.13    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Allakos Inc                        | Allakos Inc                        | CUSIP: 01671P100<br>LEI: 549300S6ZD1W6BPMDY37 | Long             | EC               | CORP              | US        |     17081 | NS      | $126911.83    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| MIRATI THERAPEUTICS INC            | MIRATI THERAPEUTICS INC            | CUSIP: 60468T105<br>LEI: 529900GYRW59IDQV6N54 | Long             | EC               | CORP              | US        |      2739 | NS      | $146289.99    | 0.88%             |  |  |  | No            |                  1 | On Loan: —       |
| Dynavax Technologies Corp          | Dynavax Technologies Corp          | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |     10367 | NS      | $117976.46    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc          | Edgewise Therapeutics Inc          | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14802 | NS      | $151424.46    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                        | Vaxcyte Inc                        | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |      2620 | NS      | $118817.00    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Seres Therapeutics Inc             | Seres Therapeutics Inc             | CUSIP: 81750R102<br>LEI: 549300GMXBE5NUWISF13 | Long             | EC               | CORP              | US        |     19344 | NS      | $105811.68    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Codexis Inc                        | Codexis Inc                        | CUSIP: 192005106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21460 | NS      | $131979.00    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| CinCor Pharma Inc                  | CinCor Pharma Inc                  | CUSIP: 17240Y109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9879 | NS      | $285799.47    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Affimed NV                         | Affimed NV                         | CUSIP: 000000000<br>LEI: 5493004V4FSXT1D04610 | Long             | EC               | CORP              | DE        |    101477 | NS      | $130905.33    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                      | Altimmune Inc                      | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |     11107 | NS      | $151499.48    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Inhibrx Inc                        | Inhibrx Inc                        | CUSIP: 45720L107<br>LEI: 549300VBKG2LTV1TLY22 | Long             | EC               | CORP              | US        |      4071 | NS      | $101775.00    | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc         | Syndax Pharmaceuticals Inc         | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |      4873 | NS      | $139855.10    | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| I-Mab                              | I-Mab                              | CUSIP: 44975P103<br>LEI: 549300L1A5T19703RR64 | Long             | EC               | CORP              | CN        |     31182 | NS      | $187715.64    | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals Inc           | Atea Pharmaceuticals Inc           | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     27152 | NS      | $125713.76    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                   | Nuvation Bio Inc                   | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     66522 | NS      | $163644.12    | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                     | Immunovant Inc                     | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7930 | NS      | $140916.10    | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc          | Allogene Therapeutics Inc          | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15471 | NS      | $119436.12    | 0.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Crinetics Pharmaceuticals Inc      | Crinetics Pharmaceuticals Inc      | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |      7350 | NS      | $144133.50    | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Precigen Inc                       | Precigen Inc                       | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |     70024 | NS      | $113438.88    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences Inc                | Kodiak Sciences Inc                | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |     16426 | NS      | $132722.08    | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc              | Dyne Therapeutics Inc              | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8676 | NS      | $126669.60    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Inovio Pharmaceuticals Inc         | Inovio Pharmaceuticals Inc         | CUSIP: 45773H201<br>LEI: 529900B9W875XDZXTM97 | Long             | EC               | CORP              | US        |     64033 | NS      | $106294.78    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc     | Day One Biopharmaceuticals Inc     | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5542 | NS      | $120649.34    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                       | Biohaven Ltd                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7622 | NS      | $145503.98    | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Scilex Holding Co                  | Scilex Holding Co                  | CUSIP: 80880W106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17635 | NS      | $125228.48    | 0.75%             |  |  |  | Yes           |                  2 | On Loan: No      |
| Chinook Therapeutics Inc           | Chinook Therapeutics Inc           | CUSIP: 16961L106<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |      4796 | NS      | $121194.92    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Cassava Sciences Inc               | Cassava Sciences Inc               | CUSIP: 14817C107<br>LEI: 529900XA0UG5JXABYF08 | Long             | EC               | CORP              | US        |      2715 | NS      | $76020.00     | 0.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Xencor Inc                         | Xencor Inc                         | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |      4199 | NS      | $138231.08    | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc            | Kymera Therapeutics Inc            | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4043 | NS      | $151127.34    | 0.91%             |  |  |  | No            |                  1 | On Loan: —       |
| Kura Oncology Inc                  | Kura Oncology Inc                  | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |      9091 | NS      | $125637.62    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Lyell Immunopharma Inc             | Lyell Immunopharma Inc             | CUSIP: 55083R104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     33635 | NS      | $109986.45    | 0.66%             |  |  |  | No            |                  1 | On Loan: —       |
| ALX Oncology Holdings Inc          | ALX Oncology Holdings Inc          | CUSIP: 00166B105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10672 | NS      | $99249.60     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Verve Therapeutics Inc             | Verve Therapeutics Inc             | CUSIP: 92539P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5295 | NS      | $120461.25    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Oncology Inc              | Cullinan Oncology Inc              | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10045 | NS      | $116923.80    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Alector Inc                        | Alector Inc                        | CUSIP: 014442107<br>LEI: 549300Z8RQOIY1JMHC25 | Long             | EC               | CORP              | US        |     12765 | NS      | $112587.30    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Cerevel Therapeutics Holdings      | Cerevel Therapeutics Holdings Inc  | CUSIP: 15678U128<br>LEI: 254900RJNIRS9COSQR41 | Long             | EC               | CORP              | US        |      4455 | NS      | $152138.25    | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Ventyx Biosciences Inc             | Ventyx Biosciences Inc             | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3527 | NS      | $148134.00    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Kezar Life Sciences Inc            | Kezar Life Sciences Inc            | CUSIP: 49372L100<br>LEI: 549300EV1V8GXBV18004 | Long             | EC               | CORP              | US        |     16607 | NS      | $119072.19    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Editas Medicine Inc                | Editas Medicine Inc                | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               | CORP              | US        |     11558 | NS      | $114308.62    | 0.69%             |  |  |  | No            |                  1 | On Loan: —       |
| Summit Therapeutics Inc            | Summit Therapeutics Inc            | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36619 | NS      | $129997.45    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| DICE Therapeutics Inc              | DICE Therapeutics Inc              | CUSIP: 23345J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3529 | NS      | $112116.33    | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Zentalis Pharmaceuticals Inc       | Zentalis Pharmaceuticals Inc       | CUSIP: 98943L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5992 | NS      | $141411.20    | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Reata Pharmaceuticals Inc          | Reata Pharmaceuticals Inc          | CUSIP: 75615P103<br>LEI: 5299005F094GH9QDDD80 | Long             | EC               | CORP              | US        |      3399 | NS      | $147278.67    | 0.89%             |  |  |  | No            |                  1 | On Loan: —       |
| Celldex Therapeutics Inc           | Celldex Therapeutics Inc           | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |      2974 | NS      | $131034.44    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                        | Arcellx Inc                        | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3629 | NS      | $121244.89    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                     | AnaptysBio Inc                     | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      4082 | NS      | $101600.98    | 0.61%             |  |  |  | No            |                  1 | On Loan: —       |
| Pliant Therapeutics Inc            | Pliant Therapeutics Inc            | CUSIP: 729139105<br>LEI: 5493002Q5LITR7VHZH02 | Long             | EC               | CORP              | US        |      6243 | NS      | $218754.72    | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| IGM Biosciences Inc                | IGM Biosciences Inc                | CUSIP: 449585108<br>LEI: 5493008XCQES2N0VY969 | Long             | EC               | CORP              | US        |      6050 | NS      | $137516.50    | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc               | Compass Pathways Plc               | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |     11880 | NS      | $123314.40    | 0.74%             |  |  |  | No            |                  1 | On Loan: —       |
| TG Therapeutics Inc                | TG Therapeutics Inc                | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     13086 | NS      | $199299.78    | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp                         | Geron Corp                         | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |     50954 | NS      | $168148.20    | 1.01%             |  |  |  | No            |                  1 | On Loan: No      |
| 4D Molecular Therapeutics Inc      | 4D Molecular Therapeutics Inc      | CUSIP: 35104E100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4899 | NS      | $103123.95    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                       | Nuvalent Inc                       | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3702 | NS      | $111985.50    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc             | Nurix Therapeutics Inc             | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9688 | NS      | $119065.52    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc       | Protagonist Therapeutics Inc       | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12169 | NS      | $161726.01    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Prothena Corp PLC                  | Prothena Corp PLC                  | CUSIP: 000000000<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |      2066 | NS      | $116832.30    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Morphic Holding Inc                | Morphic Holding Inc                | CUSIP: 61775R105<br>LEI: 549300RWWOUFLHTY1224 | Long             | EC               | CORP              | US        |      4359 | NS      | $142670.07    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc             | Stoke Therapeutics Inc             | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     14289 | NS      | $142318.44    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                         | Erasca Inc                         | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24740 | NS      | $98960.00     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                         | uniQure NV                         | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |      5091 | NS      | $108183.75    | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics Inc           | Sangamo Therapeutics Inc           | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |     34708 | NS      | $121130.92    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Immatics NV                        | Immatics NV                        | CUSIP: 000000000<br>LEI: 984500DC691EZ96AF394 | Long             | EC               | CORP              | DE        |     12396 | NS      | $100531.56    | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                      | Zymeworks Inc                      | CUSIP: 98985Y108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18652 | NS      | $176261.40    | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Amyris Inc                         | Amyris Inc                         | CUSIP: 03236M200<br>LEI: 549300BG17WCUK6EIM58 | Long             | EC               | CORP              | US        |     68035 | NS      | $108175.65    | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Intellia Therapeutics Inc          | Intellia Therapeutics Inc          | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |      3086 | NS      | $130969.84    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Allovir Inc                        | Allovir Inc                        | CUSIP: 019818103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17872 | NS      | $103300.16    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc             | Akero Therapeutics Inc             | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |      2704 | NS      | $133848.00    | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| SpringWorks Therapeutics Inc       | SpringWorks Therapeutics Inc       | CUSIP: 85205L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5110 | NS      | $160454.00    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc                | Replimune Group Inc                | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |      4291 | NS      | $119504.35    | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| FIBROGEN INC                       | FIBROGEN INC                       | CUSIP: 31572Q808<br>LEI: 549300Q914ULWWY95822 | Long             | EC               | CORP              | US        |      7947 | NS      | $187549.20    | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| ATAI Life Sciences NV              | ATAI Life Sciences NV              | CUSIP: 000000000<br>LEI: 391200Z8UWPJSNBNCA11 | Long             | EC               | CORP              | DE        |     38626 | NS      | $68754.28     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Repare Therapeutics Inc            | Repare Therapeutics Inc            | CUSIP: 760273102<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |      8058 | NS      | $99596.88     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Karuna Therapeutics Inc            | Karuna Therapeutics Inc            | CUSIP: 48576A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       585 | NS      | $116643.15    | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                   | Cytokinetics Inc                   | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |      2893 | NS      | $122894.64    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| C4 Therapeutics Inc                | C4 Therapeutics Inc                | CUSIP: 12529R107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14620 | NS      | $113889.80    | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc             | Cogent Biosciences Inc             | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9896 | NS      | $149033.76    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG             | CRISPR Therapeutics AG             | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |      2385 | NS      | $121682.70    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc              | Vir Biotechnology Inc              | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4624 | NS      | $136639.20    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| RAPT Therapeutics Inc              | RAPT Therapeutics Inc              | CUSIP: 75382E109<br>LEI: 549300MB473BIU78ES48 | Long             | EC               | CORP              | US        |      6519 | NS      | $189376.95    | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| IVERIC bio Inc                     | IVERIC bio Inc                     | CUSIP: 46583P102<br>LEI: 549300GZXI59U71XPM70 | Long             | EC               | CORP              | US        |      5375 | NS      | $124162.50    | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC           | Bicycle Therapeutics PLC           | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |      3729 | NS      | $102994.98    | 0.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Rocket Pharmaceuticals Inc         | Rocket Pharmaceuticals Inc         | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |      5260 | NS      | $114299.80    | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc      | Recursion Pharmaceuticals Inc      | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13116 | NS      | $109256.28    | 0.66%             |  |  |  | No            |                  1 | On Loan: —       |
| Caribou Biosciences Inc            | Caribou Biosciences Inc            | CUSIP: 142038108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14673 | NS      | $105792.33    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-03-22

**Name of Applicant:** ETFis Series Trust I

**Signature:** Brinton W. Frith

**Name of Signer:** Brinton W. Frith

**Title:** Treasurer and Principal Financial Officer